Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 24 | $29,190,938 |
| Sells | 13 | $344,944,826 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 28 Jan 2025 17:23 | XOMA | XOMA Royalty Corp | BVF PARTNERS L P/IL | 10% | 24 Jan 2025 | Sale | 339,679 | 26.1 | 8,865,622 | D |
| 28 Jan 2025 17:23 | XOMA | XOMA Royalty Corp | BVF PARTNERS L P/IL | 10% | 24 Jan 2025 | Sale | 85,776 | 26.1 | 2,238,754 | D |
| 28 Jan 2025 17:23 | XOMA | XOMA Royalty Corp | BVF PARTNERS L P/IL | 10% | 24 Jan 2025 | Sale | 75,287 | 26.1 | 1,964,991 | D |
| 28 Jan 2025 17:23 | XOMA | XOMA Royalty Corp | BVF PARTNERS L P/IL | 10% | 24 Jan 2025 | Sale | 149,975 | 26.1 | 3,914,348 | I |
| 31 Oct 2024 17:53 | THRD | Third Harmonic Bio Inc | BVF PARTNERS L P/IL | See Explanation of Responses | 29 Oct 2024 | Sale | 538,420 | 14.3 | 7,699,406 | D |
| 31 Oct 2024 17:53 | THRD | Third Harmonic Bio Inc | BVF PARTNERS L P/IL | See Explanation of Responses | 29 Oct 2024 | Sale | 396,963 | 14.3 | 5,676,571 | D |
| 31 Oct 2024 17:53 | THRD | Third Harmonic Bio Inc | BVF PARTNERS L P/IL | See Explanation of Responses | 29 Oct 2024 | Sale | 64,617 | 14.3 | 924,023 | D |
| 08 Oct 2024 18:50 | MLTX | MoonLake Immunotherapeutics | BVF PARTNERS L P/IL | Director , 10% | 04 Oct 2024 | Sale | 1,030,589 | 50.0016 | 51,531,099 | D |
| 08 Oct 2024 18:50 | MLTX | MoonLake Immunotherapeutics | BVF PARTNERS L P/IL | Director , 10% | 04 Oct 2024 | Sale | 836,862 | 50.0016 | 41,844,439 | D |
| 08 Oct 2024 18:50 | MLTX | MoonLake Immunotherapeutics | BVF PARTNERS L P/IL | Director , 10% | 04 Oct 2024 | Sale | 132,549 | 50.0016 | 6,627,662 | D |
| 13 May 2024 17:04 | ELDN | Eledon Pharmaceuticals Inc | BVF PARTNERS L P/IL | 10% | 09 May 2024 | Purchase | 75,431 | 0 | 0 | D |
| 13 May 2024 17:04 | ELDN | Eledon Pharmaceuticals Inc | BVF PARTNERS L P/IL | 10% | 09 May 2024 | Purchase | 821,121 | 0 | 0 | D |
| 13 May 2024 17:04 | ELDN | Eledon Pharmaceuticals Inc | BVF PARTNERS L P/IL | 10% | 09 May 2024 | Purchase | 1,031,385 | 0 | 0 | D |
| 20 Dec 2023 18:09 | PNT | POINT Biopharma Global Inc | BVF PARTNERS L P/IL | Former 10% Owner | 18 Dec 2023 | Sale | 896,366 | 12.45 | 11,159,757 | D |
| 20 Dec 2023 18:09 | PNT | POINT Biopharma Global Inc | BVF PARTNERS L P/IL | Former 10% Owner | 18 Dec 2023 | Sale | 7,290,667 | 12.45 | 90,768,804 | D |
| 20 Dec 2023 18:09 | PNT | POINT Biopharma Global Inc | BVF PARTNERS L P/IL | Former 10% Owner | 18 Dec 2023 | Sale | 8,974,245 | 12.45 | 111,729,350 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 16 Nov 2023 | Purchase | 16,143 | 5.3837 | 86,909 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 16 Nov 2023 | Purchase | 125,909 | 5.3837 | 677,856 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 16 Nov 2023 | Purchase | 153,693 | 5.3837 | 827,437 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 15 Nov 2023 | Purchase | 47,712 | 4.9999 | 238,555 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 15 Nov 2023 | Purchase | 390,507 | 4.9999 | 1,952,496 | D |
| 17 Nov 2023 16:54 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 15 Nov 2023 | Purchase | 493,337 | 4.9999 | 2,466,636 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 10,106 | 14.0689 | 142,180 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 103,885 | 14.0689 | 1,461,548 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 83,708 | 14.0689 | 1,177,679 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 02 Nov 2023 | Purchase | 26,772 | 11.6444 | 311,744 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 02 Nov 2023 | Purchase | 132,016 | 11.6444 | 1,537,247 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 02 Nov 2023 | Purchase | 57,618 | 11.6444 | 670,927 | D |
| 03 Nov 2023 17:37 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 02 Nov 2023 | Purchase | 72,479 | 3.6 | 260,924 | D |
| 03 Nov 2023 17:37 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 02 Nov 2023 | Purchase | 492,251 | 3.6 | 1,772,104 | D |
| 03 Nov 2023 17:37 | RPTX | Repare Therapeutics Inc | BVF PARTNERS L P/IL | 10% | 02 Nov 2023 | Purchase | 218,979 | 3.6 | 788,324 | D |
| 14 Sep 2023 16:25 | OLMA | Olema Pharmaceuticals Inc | BVF PARTNERS L P/IL | Director , 10% | 12 Sep 2023 | Purchase | 52,801 | 9.84 | 519,562 | D |
| 14 Sep 2023 16:25 | OLMA | Olema Pharmaceuticals Inc | BVF PARTNERS L P/IL | Director , 10% | 12 Sep 2023 | Purchase | 677,853 | 9.84 | 6,670,074 | D |
| 14 Sep 2023 16:25 | OLMA | Olema Pharmaceuticals Inc | BVF PARTNERS L P/IL | Director , 10% | 12 Sep 2023 | Purchase | 775,278 | 9.84 | 7,628,736 | D |
| 09 May 2023 20:25 | ELDN | Eledon Pharmaceuticals Inc | BVF PARTNERS L P/IL | 10% | 05 May 2023 | Purchase | 86,341 | 0 | 0 | D |
| 09 May 2023 20:25 | ELDN | Eledon Pharmaceuticals Inc | BVF PARTNERS L P/IL | 10% | 05 May 2023 | Purchase | 837,146 | 0 | 0 | D |
| 09 May 2023 20:25 | ELDN | Eledon Pharmaceuticals Inc | BVF PARTNERS L P/IL | 10% | 05 May 2023 | Purchase | 1,055,445 | 0 | 0 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)